There was a 21% increased risk of ovarian cancer associated with the rs1805386 variant in LIG4 among heterozygous carriers and a 34% increased risk among homozygous carriers (P=0.013 and P=0.15, respectively; Table 3) in the original data. This evidence concerns the gene LIG4 and ovarian cancer.